AIG
MRNS

American International Group’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

American International Group’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-26,982
Closed -$244K – 2982
2024
Q1 		$244K Buy
26,982
+1,776
+7% +$17.3K ﹤0.01% 2037
2023
Q4 		$274K Sell
25,206
-101
-0.4% -$757 ﹤0.01% 2003
2023
Q3 		$204K Buy
25,307
+1,325
+6% +$11K ﹤0.01% 2112
2023
Q2 		$260K Buy
+23,982
New +$205K ﹤0.01% 2022
2022
Q2 		– Sell
-18,337
Closed -$171K – 3316
2022
Q1 		$171K Sell
18,337
-1,291
-7% -$12.8K ﹤0.01% 2337
2021
Q4 		$233K Sell
19,628
-587
-3% -$6.78K ﹤0.01% 2278
2021
Q3 		$230K Sell
20,215
-481
-2% -$6.61K ﹤0.01% 2355
2021
Q2 		$371 Buy
20,696
+3,718
+22% +$59.8K ﹤0.01% 2119
2021
Q1 		$263 Buy
16,978
+2,439
+17% +$35.3K ﹤0.01% 2214
2020
Q4 		$177 Sell
14,539
-417
-3% -$5.81K ﹤0.01% 2343
2020
Q3 		$192K Buy
14,956
+2,001
+15% +$17.3K ﹤0.01% 2173
2020
Q2 		$132K Buy
12,955
+793
+7% +$7.29K ﹤0.01% 2351
2020
Q1 		$99K Buy
12,162
+4,110
+51% +$35.6K ﹤0.01% 2311
2019
Q4 		$70K Buy
8,052
+130
+2% +$730 ﹤0.01% 2786
2019
Q3 		$49K Sell
7,922
-55
-0.7% -$444 ﹤0.01% 2894
2019
Q2 		$132K Buy
7,977
+453
+6% +$7.87K ﹤0.01% 2499
2019
Q1 		$126K Buy
7,524
+1,532
+26% +$22.1K ﹤0.01% 2489
2018
Q4 		$69K Sell
5,992
-46
-0.8% -$931 ﹤0.01% 2777
2018
Q3 		$242K Buy
6,038
+108
+2% +$3.07K ﹤0.01% 2318
2018
Q2 		$168K Buy
+5,930
New +$131K ﹤0.01% 2467

Other funds holding MRNS

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

American International Group's MRNS Position: Q2 2024 in Review

American International Group sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q2 2024, closing a stake of 26,982 shares — an estimated $244K sold.

American International Group first reported a position in MRNS in Q2 2018 and held it in 20 quarters. The position peaked at $274K in Q4 2023. 90 funds tracked by Wall St. Rank hold MRNS as of Q2 2024.

  • American International Group reported no remaining Marinus Pharmaceuticals, Inc position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 26,982 Marinus Pharmaceuticals, Inc shares in Q2 2024, an estimated $244K.
  • American International Group first reported a position in Marinus Pharmaceuticals, Inc in Q2 2018 and held it in 20 quarters.
  • American International Group's Marinus Pharmaceuticals, Inc position peaked at $274K in Q4 2023.
  • 90 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.